Pay in 4 interest-free payments of $11.25 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
Janeta Popovici-Muller
Combined treatment with sodium butyrate and PD153035 enhances keratinocyte differentiation
Inhibitors of Hedgehog acyltransferase block Sonic Hedgehog signaling
Rajagopal S
CFTR Inhibitor II blocks the open pore of cardiac CFTR channels at an electrical distance of 0
KPT-330 - CAS# 1393477-72-9 009 Janeta Popovici-MullerKPT 330, CAS No. 1393477 72 9, is an orally bioavailable, potent and selective XPO1 CRM1 Inhibitor. KPT 330 is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia. KPT 330 potentiates the antitumor activity of gemcitabine in human pancreatic cancer through inhibition of tumor growth, depletion of the antiapoptotic proteins, and induction of apoptosis. KPT 330 has strong activity against primary